Recall Ledger

0.9% Sodium Chloride Injection recall (Fresenius Kabi USA, LLC)

DrugClass IIOngoing

Summary: Fresenius Kabi USA, LLC is recalling 0.9% Sodium Chloride Injection, USP 0.9% (450 mg per 50 mL) (9 mg per mL) 50 mL, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-466-05, Unit of Sale NDC Number: 65219-466-60.. Reason: Lack of Assurance of Sterility.

What is being recalled

0.9% Sodium Chloride Injection, USP 0.9% (450 mg per 50 mL) (9 mg per mL) 50 mL, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-466-05, Unit of Sale NDC Number: 65219-466-60.

Why

Lack of Assurance of Sterility

How serious is it

Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.

Where it was sold

US Nationwide , Alaska, and Puerto Rico. (states named: Alaska, Puerto Rico)

How to tell if yours is affected

Batch# 6402372, 6402374, Exp Date: 08/31/2026; Batch# 6402437, Exp Date: 10/31/2026.

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0425-2026
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass II
StatusOngoing
Recall startedMarch 11, 2026
ReportedApril 15, 2026
CompanyFresenius Kabi USA, LLC
Company locationLake Zurich, IL, United States
Initiated byVoluntary: Firm initiated

More recalls from Fresenius Kabi USA, LLC · all drug recalls · recalls from March 2026

Official FDA record